期刊
EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 15, 期 7, 页码 741-752出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737175.2015.1051968
关键词
chemoresistance; glioma stem cells; malignant glioma; mechanisms; plasticity recurrence
资金
- NCI [R01CA122930, R01CA138587]
- NIH [R01NS077388]
- National Institute of Neurological Disorders and Stroke [U01NS069997]
- American Cancer Society [RSG-07-276-01-MGO]
Glioma stem cells (GSCs) constitute a slow-dividing, small population within a heterogeneous glioblastoma. They are able to self-renew, recapitulate a whole tumor, and differentiate into other specific glioblastoma multiforme (GBM) subpopulations. Therefore, they have been held responsible for malignant relapse after primary standard therapy and the poor prognosis of recurrent GBM. The failure of current therapies to eliminate specific GSC subpopulations has been considered a major factor contributing to the inevitable recurrence in GBM patients after treatment. Here, we discuss the molecular mechanisms of chemoresistance of GSCs and the reasons why complete eradication of GSCs is so difficult to achieve. We will also describe the targeted therapies currently available for GSCs and possible mechanisms to overcome such chemoresistance and avoid therapeutic relapse.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据